Published in Br J Cancer on April 01, 2000
Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest (2005) 2.61
Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis (2008) 1.69
Why integrin as a primary target for imaging and therapy. Theranostics (2011) 1.61
Defining the role of integrin alphavbeta6 in cancer. Curr Drug Targets (2009) 1.16
From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker. Bioconjug Chem (2013) 0.95
Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells. Br J Cancer (2002) 0.92
Epithelial integrins with special reference to oral epithelia. J Dent Res (2011) 0.90
Molecular changes in invasive front of oral cancer. J Oral Maxillofac Pathol (2013) 0.88
Oxidative stress induced mechanisms in the progression of periodontal diseases and cancer: a common approach to redox homeostasis? Cancers (Basel) (2010) 0.87
A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density. PLoS One (2013) 0.85
Integrin Regulation of Epidermal Functions in Wounds. Adv Wound Care (New Rochelle) (2014) 0.85
Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆. Bioorg Med Chem (2011) 0.83
Molecular imaging of integrin αvβ6 expression in living subjects. Am J Nucl Med Mol Imaging (2014) 0.77
Integrin-mediated regulation of epidermal wound functions. Cell Tissue Res (2016) 0.75
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell (1999) 11.59
Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature (1997) 8.52
Integrins. J Clin Invest (1991) 6.05
Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer (1984) 4.46
The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol (1990) 3.82
TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell (1996) 3.73
Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci (1995) 3.27
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med (1982) 3.27
Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J Cell Biol (1996) 3.18
Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol (1991) 2.88
Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes. Proc Natl Acad Sci U S A (1990) 2.83
Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues. J Histochem Cytochem (1993) 2.22
Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med (1998) 2.03
Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sci U S A (1993) 1.89
Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol (1995) 1.85
Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest (1993) 1.80
Complete amino acid sequence of a novel integrin beta subunit (beta 6) identified in epithelial cells using the polymerase chain reaction. J Biol Chem (1990) 1.76
Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas. J Clin Invest (1989) 1.52
Prospective investigation of tumor markers and risk assessment in early cancer screening. Cancer (1994) 1.50
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes. J Cell Biol (1991) 1.42
Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer (1993) 1.36
Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules. Am J Pathol (1991) 1.34
Keratinocytes in human wounds express alpha v beta 6 integrin. J Invest Dermatol (1996) 1.32
Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol (1992) 1.31
Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. Br J Cancer (1990) 1.25
Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases. Am J Pathol (1991) 1.22
Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J Oral Pathol Med (1997) 1.21
Epithelial integrins. Bioessays (1996) 1.18
Integrin expression in primary breast cancer and its relation to axillary nodal status. Surgery (1995) 1.16
Low expression of beta 1, alpha 2 and alpha 3 subunits of VLA integrins in malignant mammary tumours. J Pathol (1991) 1.09
Precancer and cancer in inflammatory bowel disease. Pathology (1985) 1.07
Re-epithelialization of normal human excisional wounds is associated with a switch from alpha v beta 5 to alpha v beta 6 integrins. Br J Dermatol (1996) 1.07
Distribution of integrins alpha v beta 6 and alpha 9 beta 1 and their known ligands, fibronectin and tenascin, in human airways. Am J Respir Cell Mol Biol (1995) 1.05
Expression and function of the keratinocyte integrins. Dev Suppl (1993) 1.04
Keratinocytes and cytokine/growth factors. Crit Rev Oral Biol Med (1996) 0.99
Expression of the VLA beta 1 integrin family in bladder cancer. Am J Pathol (1994) 0.96
Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol (1995) 0.92
Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer. Science (1982) 0.91
Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer. Br J Cancer (1996) 0.91
Identification of specific human epithelial cell integrin receptors as VLA proteins. Exp Cell Res (1990) 0.88
Loss of alpha 6 and beta 4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. J Pathol (1993) 0.87
Expression of epithelial adhesion proteins and integrins in chronic inflammation. Am J Pathol (1995) 0.85
Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions. J Natl Cancer Inst (1997) 0.83
Keratinocyte integrins in wound healing and chronic inflammation of the human periodontium. Oral Dis (1996) 0.82
Immunological investigation of adult patients with primary herpes simplex virus-1 infection. J Oral Pathol Med (1993) 0.80
Gal-GalNAc: a biomarker of colon carcinogenesis. Histol Histopathol (1996) 0.79
Destruction of the epithelial anchoring system in lichen planus. J Invest Dermatol (1995) 0.78
Issues in assessment of diagnostic tests and risk for periodontal diseases. Periodontol 2000 (1995) 0.76
Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations. Blood (1998) 2.60
Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med (1999) 2.39
Undergraduate education in emergency medicine. Ann Emerg Med (1990) 2.36
Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc Natl Acad Sci U S A (2001) 2.27
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25
Herpesvirus infections in the acquired immune deficiency syndrome. JAMA (1984) 2.25
Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta (1987) 2.06
The proliferative potential of myeloma plasma cells manifest in the SCID-hu host. Blood (1999) 2.02
Remodelling of adipose tissue during experimental omental adhesion formation. Br J Surg (2008) 2.02
The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions. J Dent Res (1998) 2.01
Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci U S A (1989) 1.97
Latex allergies in dentistry: recognition and recommendations. J Can Dent Assoc (1997) 1.95
Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci (2001) 1.94
Challenges to implementation of the new Coroners' (Amendment) Rules 2005: experience from a tertiary paediatric pathology centre. Med Sci Law (2007) 1.92
Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood (1999) 1.89
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem (1997) 1.82
Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest (1993) 1.80
Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis (2004) 1.79
Biocompatibility of nickel-titanium shape memory metal and its corrosion behavior in human cell cultures. J Biomed Mater Res (1997) 1.67
Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci U S A (2001) 1.63
Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest (1994) 1.62
Selecting the future doctors: the role of graduate medical programmes. Intern Med J (2005) 1.61
Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry (1999) 1.60
Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem (1991) 1.59
Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood (1996) 1.56
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. Blood (2000) 1.52
Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood (1994) 1.52
Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas. J Clin Invest (1989) 1.52
Emergency medicine--no longer a casualty. Med J Aust (1989) 1.50
The use of external data sources and ratio estimation to improve estimates of hardcore drug use from the NHSDA. NIDA Res Monogr (1997) 1.49
Cell biology of gingival wound healing. Periodontol 2000 (2000) 1.46
A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res (1997) 1.46
Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. J Biol Chem (1983) 1.45
Increased emphasis of medically necessary oral health care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.42
Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem (1995) 1.42
[The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups]. Med Clin (Barc) (1991) 1.40
High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood (2000) 1.39
Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res (1998) 1.39
Preventable death studies: an inappropriate tool for evaluating trauma systems. Aust N Z J Surg (1997) 1.39
Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res (1994) 1.38
Does care exclude cure in palliative care? J Palliat Care (1986) 1.38
Cytopathic effects of Treponema denticola chymotrypsin-like proteinase on migrating and stratified epithelial cells. Infect Immun (1995) 1.37
Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry (1997) 1.35
Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol (1995) 1.35
A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun (1989) 1.35
Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood (1993) 1.34
Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry (2000) 1.33
Keratinocytes in human wounds express alpha v beta 6 integrin. J Invest Dermatol (1996) 1.32
Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology (2011) 1.32
Compliance with infection control procedures in a dental hospital clinic. Br Dent J (1992) 1.32
Cysteine cathepsins in human carious dentin. J Dent Res (2011) 1.32
Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells--role in metastasis. Int J Cancer (1982) 1.31
Chromosome 13 homozygosity in osteosarcoma without retinoblastoma. Am J Hum Genet (1986) 1.30
Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem (1999) 1.30
Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood (1999) 1.30
Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem (1984) 1.28
Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol (2004) 1.27
An immunoassay to detect human müllerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab (1990) 1.26
Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res (1999) 1.26
The esterase activity in megaloblasts, leukaemic and normal haemopoietic cells. Br J Haematol (1968) 1.25
VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma. Leukemia (2008) 1.25
Plasma cell myeloma--new biological insights and advances in therapy. Blood (1989) 1.25
Sensitivity of barley varieties to weather in Finland. J Agric Sci (2011) 1.22
Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med (2001) 1.21
Deficient DNA repair in human progeroid cells. Proc Natl Acad Sci U S A (1973) 1.20
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19
Degradation of basement membrane collagen by proteases from some anaerobic oral micro-organisms. Oral Microbiol Immunol (1988) 1.18
Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol (2002) 1.17
Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr (1992) 1.16
The effects of MMP inhibitors on human salivary MMP activity and caries progression in rats. J Dent Res (2001) 1.16
Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood (1993) 1.16
The localization of matrix metalloproteinase-20 (MMP-20, enamelysin) in mature human teeth. J Dent Res (2002) 1.14
In vivo analyses of integrin beta 1 subunit function in fibronectin matrix assembly. J Cell Biol (1990) 1.13
The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone. Exp Hematol (1998) 1.11
The LN54 radiation hybrid map of zebrafish expressed sequences. Genome Res (2001) 1.11
In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis. J Pathol (2001) 1.10
Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. Cancer Res (1998) 1.10
Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma. Oral Oncol (2009) 1.10
Ultrasonography of salivary glands in primary Sjogren's syndrome. A comparison with magnetic resonance imaging and magnetic resonance sialography of parotid glands. Rheumatology (Oxford) (2004) 1.10
Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res (2006) 1.09
New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol (1998) 1.08
Human fear-related motor neurocircuitry. Neuroscience (2007) 1.07
Expression of matrix metalloproteinase-13 in odontoblast-like cells. Int Endod J (2013) 1.07
Re-epithelialization of normal human excisional wounds is associated with a switch from alpha v beta 5 to alpha v beta 6 integrins. Br J Dermatol (1996) 1.07
Synthesis of hyaluronic acid and collagen in skin fibroblasts cultured from patients with osteogenesis imperfecta. Biochim Biophys Acta (1980) 1.06
A role for decorin in the structural organization of periodontal ligament. Lab Invest (2000) 1.06
Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. Br J Cancer (2013) 1.06
Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci (1994) 1.06
MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci (1999) 1.05
An improved method for culture of epidermal keratinocytes from newborn mouse skin. Methods Cell Sci (2001) 1.05
Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer (2000) 1.05